NDC 52652-3001

Qbrelis

Lisinopril

Qbrelis is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Silvergate Pharmaceuticals, Inc.. The primary component is Lisinopril.

Product ID52652-3001_017ddcae-b674-406b-b2f4-7df9a7860e60
NDC52652-3001
Product TypeHuman Prescription Drug
Proprietary NameQbrelis
Generic NameLisinopril
Dosage FormSolution
Route of AdministrationORAL
Marketing Start Date2016-08-29
Marketing CategoryNDA / NDA
Application NumberNDA208401
Labeler NameSilvergate Pharmaceuticals, Inc.
Substance NameLISINOPRIL
Active Ingredient Strength1 mg/mL
Pharm ClassesAngiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 52652-3001-1

150 mL in 1 BOTTLE (52652-3001-1)
Marketing Start Date2016-08-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 52652-3001-1 [52652300101]

Qbrelis SOLUTION
Marketing CategoryNDA
Application NumberNDA208401
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-08-29

Drug Details

Active Ingredients

IngredientStrength
LISINOPRIL1 mg/mL

OpenFDA Data

SPL SET ID:9f6e4e57-a489-4b36-b093-b93865d3717c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1806890
  • 1806884
  • Pharmacological Class

    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]

    NDC Crossover Matching brand name "Qbrelis" or generic name "Lisinopril"

    NDCBrand NameGeneric Name
    52652-3001QbrelisQbrelis
    0143-1266LisinoprilLisinopril
    0143-1267LisinoprilLisinopril
    0143-1268LisinoprilLisinopril
    0143-1270LisinoprilLisinopril
    0143-9713LisinoprilLisinopril
    0143-9714LisinoprilLisinopril
    0143-9715LisinoprilLisinopril
    0185-0025lisinoprillisinopril
    0185-0101lisinoprillisinopril
    0185-0102lisinoprillisinopril
    0185-0103lisinoprillisinopril
    0185-0104lisinoprillisinopril
    0185-0602lisinoprillisinopril
    0185-0605lisinoprillisinopril
    0185-0610lisinoprillisinopril
    0185-0620lisinoprillisinopril
    0185-0630lisinoprillisinopril
    0185-0640lisinoprillisinopril
    0185-5400lisinoprillisinopril
    0378-2072Lisinoprillisinopril
    0378-2073Lisinoprillisinopril
    0378-2074Lisinoprillisinopril
    0378-2075Lisinoprillisinopril
    0378-2076Lisinoprillisinopril
    0006-0019PRINIVILlisinopril
    0006-0106PRINIVILlisinopril
    0006-0207PRINIVILlisinopril

    Trademark Results [Qbrelis]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    QBRELIS
    QBRELIS
    86934764 5192589 Live/Registered
    Argentum Holdings, LLC
    2016-03-09

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.